News & Events


Recent Firm Activities and Highlights

COTA
Cota Founder and Executive Chairman to Present at the Vatican’s Unite to Cure Conference
04.27.18
Cota Inc., a real-world data and analytics company bridging precision medicine to population health, today announced its founder and executive chairman, Andrew Pecora, M.D., will speak today, April 27 at the Fourth International Vatican Conference, Unite to Cure: A Global Health Care Initiative, which is being held from April 26-28 at the Aula Nuova del Sinodo in Vatican City. The event will build on the current global health care movement and unite world leaders across all disciplines to engage in powerful conversations about how science, technology and 21st century medicine will impact culture and society. Read More
COTA
HIMSS18: Interview with Stuart Goldberg, M.D. | Cota | Precision Payment
03.29.18
On this episode we talk with Stuart Goldberg, MD, Chief Scientific Officer at Cota. Dr. Goldberg tells us all about Cota’s physician-led journey to organize and classify real-world evidence about every type of cancer. This effort led to something they call the Cota Nodal Address (CNA), and it’s enabling health systems to get very specific about the types of patients they’re treating, the costs associated with them, and the outcomes being achieved. This apples-to-apples comparison allows Cota to identify variation and address it in ways that are beneficial to the provider, payer and patient. It enables a concept Dr. Goldberg calls “Precision Payment”, which in turn enables proper bundled payment design, and precision medicine. Read More
COTA
Beyond Flatiron: The Rising Power Of Oncology Clinical Data Companies
03.10.18
First, given that (as Andrew Matzkin of Health Advances observed) the Flatiron transaction is “putting smiles on a lot of faces,” what other emerging oncology clinical data companies might soon be in play? And second, more fundamentally, what are the implications of the rise of these types of companies – for both pharma and for healthcare? Read More
COTA
Cota Announces $40 Million Series C Financing to Advance its Cota Nodal Address™ Classification System and Real-World Evidence and Analytics Platforms
02.21.18
Cota Inc., a healthcare real-world evidence and data analytics company bridging precision medicine to population health, today announced the completion of a Series C round of financing led by IQVIA (NYSE: IQV) with major participation by EW Healthcare Partners. Cota will leverage this funding to scale its solutions across healthcare providers, payers and life sciences companies. The funding will also advance its proprietary Cota Nodal Address™ (CNA) system, a powerful and unique precision disease classification system built on its comprehensive real-world data set. Memorial Sloan Kettering Cancer Center also participated in the round, along with existing Cota investors which include, Boston Millennia Partners, Horizon Blue Cross Blue Shield of New Jersey, Hackensack Meridian Health and Atoc Holdings. Read More
MedAptus
MedAptus Named 2018 Top-Ranked Mobile Charge Capture Platfrom by KLAS Research
02.01.18
For the seventh time in eight years, MedAptus® has been named the Category Leader in the Mobile Charge Capture segment in the “2018 Best in KLAS Awards: Software & Services” report. The award recognizes the performance of its CHARGE PRO software product, a charge capture, management and reconciliation that improves financial performance for physicians and hospitals by accurately converting billable services into ICD-10 codes quickly and easily. The company’s top-ranking score of 91.9 reflects feedback from customers across measures evaluating vendor performance data and overall satisfaction. Read More
Bivarus
Press Ganey Acquires Bivarus, Leader in Dynamic Survey Technology
01.16.18
Press Ganey today announced the acquisition of Bivarus, a patient-centered analytics company focused on capturing real-time patient and caregiver insights through a patented dynamic survey approach. The addition of Bivarus’ capabilities complements and further expands Press Ganey’s comprehensive suite of solutions designed to help clients improve the overall safety, quality and experience of care. Read More
Boston Millennia Parters
Odyssey Logistics & Technology Expands Chicago Area Footprint to Better Serve Customer Capacity Issues
11.28.17
Danbury, Conn. (Nov. 28, 2017) – Odyssey Logistics & Technology Corporation (Odyssey) today announced that its subsidiary Linden Bulk Transportation LLC has recently expanded its bulk transportation footprint in Joliet, Illinois. The new location positions Odyssey to offer its customers additional capacity and services in the greater Chicago and Midwest region. Read More
Arthrosurface
Arthrosurface Acquires An Acellular Dermal Technology From WASAS
10.30.17
Arthrosurface, Inc. announced today that it has completed the acquisition of an acellular dermal stabilization device technology, including the intellectual property rights to and associated with this technology, from WASAS, LLC based in Fort Lauderdale, Florida. Arthrosurface plans to use this technology to develop and market a platform of novel methods to be used to correct orthopedic challenges in multiple therapeutic areas. Read More
Odyssey Logistics & Technology
Odyssey Logistics & Technology Receives Equity Investment from The Jordan Company
08.30.17
Odyssey Logistics & Technology Corporation (Odyssey), a leading global logistics provider, announced today that an affiliate of The Jordan Company has signed a definitive agreement to become the new majority shareholder in Odyssey. Read More
Bivarus
Bivarus and Community Oncology Alliance Collaborate to Improve Oncology Patient Experience
08.29.17
Bivarus, a patient-centered analytics company, has formed a partnership with the Community Oncology Alliance (COA) to help its member practices across the country improve patient experiences. COA members can now utilize Bivarus’ survey platform to satisfy the Merit-Based Incentive Payment System (MIPS) requirements for reimbursement from the Centers for Medicare & Medicaid Services (CMS). Read More
Boston Millennia Parters
BMP Insights March, 2018
03.14.18
2017 Yields Liquidity to Our Investors and a New BMP IV Partnership Begins Read Full Release
Boston Millennia Parters
Odyssey Logistics & Technology Expands Chicago Area Footprint to Better Serve Customer Capacity Issues
11.28.17
Danbury, Conn. (Nov. 28, 2017) – Odyssey Logistics & Technology Corporation (Odyssey) today announced that its subsidiary Linden Bulk Transportation LLC has recently expanded its bulk transportation footprint in Joliet, Illinois. The new location positions Odyssey to offer its customers additional capacity and services in the greater Chicago and Midwest region. Read Full Release
Boston Millennia Parters
Avizia Acquires Carena
10.10.17
Avizia, powering system-wide telehealth, today announced it has acquired Carena, a Seattle-based leading virtual care provider. The acquisition of Carena reinforces Avizia’s position as the largest and most comprehensive telehealth solutions partner for health systems nationwide. Read Full Release
Odyssey Logistics & Technology
Odyssey Logistics & Technology Receives Equity Investment from The Jordan Company
08.30.17
Odyssey Logistics & Technology Corporation (Odyssey), a leading global logistics provider, announced today that an affiliate of The Jordan Company has signed a definitive agreement to become the new majority shareholder in Odyssey. Read Full Release
PAREXEL International
Two PAREXEL Executives Named to 2017 PharmaVOICE 100
08.01.17
BOSTON, August 1, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Sy Pretorius, M.D., Senior Vice President and Chief Scientific Officer, and Evan Demestihas, M.D., RPh, Vice President, Worldwide Head of The Medical Affairs Company (TMAC), have been named to PharmaVOICE magazine’s list of the 100 most inspiring people in the life sciences industry. The honor, published in the July/August 2017 issue of PharmaVOICE, recognizes both leaders for their valuable contributions to the industry and dedication to improving patients’ lives, while also mentoring the next generation of industry leaders. Read Full Release
PAREXEL International
PAREXEL International Enters Definitive Agreement to be Acquired by Pamplona Capital Management for $88.10 Per Share in Cash
06.20.17
BOSTON and NEW YORK, June 20, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, and Pamplona Capital Management, LLP (Pamplona) today announced that they have entered into a definitive agreement under which Pamplona will acquire all of the outstanding shares of PAREXEL for $88.10 per share in cash in a transaction valued at approximately $5.0 billion, including PAREXEL’s net debt. Read Full Release
Odyssey Logistics & Technology
Odyssey Logistics & Technology Posts Eight Percent Growth; Continues fourteen year trend of consecutive growth
02.02.17
Danbury, Conn. (Feb. 2, 2017) — Odyssey Logistics & Technology Corporation (Odyssey) announced today that it has posted fourteen consecutive years of growth, with net revenue up eight percent in 2016. The company attributes this year’s results to sustaining its leadership position in complex key markets, implementing operational efficiencies and maximizing benefits from the acquisition of Linden Bulk Transportation. Read Full Release
COTA
BMP Invests in COTA
12.20.16
Boston Millennia Partners Invests in Cota, Inc. Boston, MA, December 2016, Boston Millennia Partners is pleased to announce its investment in Cota, Inc. as part of an $18 million growth equity round. Cota is a New York City based cancer outcomes and data tracking company that uses a patented digital classification system to assess patient results on specific treatment protocols. Cota’s customers include pharmaceutical companies, healthcare providers and insurance companies. The company has partnerships with several major pharmaceutical companies in the U.S. including Novartis and Celgene, and with data provider Foundation Medicine. The company has received strategic investments from Novartis, Celgene, Foundation Medicine and Horizon Healthcare. Read Full Release
Collegium Pharmaceutical
Jeffries Key Takeaway: Another Formulary Win Further Positions Xtampza for a Potential 1H17 Inflection
12.15.16
COLL announced another formulary “win” for Xtampza following successful contracting with ESRX, the largest US pharmacy benefits manager (PBM). Starting January 1, 2017, Xtampza will be added to ESRX’s formulary as a preferred brand with access to another 28M commercial lives. Based on steady progress with the launch and managed care wins, we continue to believe that Xtampza Rxs are positioned for an inflection in 1H17 and see the drug as a $400M+ peak product. Read Full Release
Boston Millennia Parters
Report of the Cancer Moonshot Task Force
10.17.16
While bold, the goal of the Cancer Moonshot is within our grasp. Today, society has the benefit of decades of scientific understanding and vast amounts of rich data just waiting to be transformed into solutions. We now know that cancer is hundreds of diseases, largely of our genome, and we have developed new and innovative ways of capitalizing on this knowledge. We know that our behavior and environment contribute to our likelihood of getting cancer, and we are modifying our behaviors and exposures to avoid known risks. We know that prevention and early diagnosis are key to fighting cancer, and we can build these efforts into clinical care. Read Full Release
COTA
HIMSS18: Interview with Stuart Goldberg, M.D. | Cota | Precision Payment
03.29.18
On this episode we talk with Stuart Goldberg, MD, Chief Scientific Officer at Cota. Dr. Goldberg tells us all about Cota’s physician-led journey to organize and classify real-world evidence about every type of cancer. This effort led to something they call the Cota Nodal Address (CNA), and it’s enabling health systems to get very specific about the types of patients they’re treating, the costs associated with them, and the outcomes being achieved. This apples-to-apples comparison allows Cota to identify variation and address it in ways that are beneficial to the provider, payer and patient. It enables a concept Dr. Goldberg calls “Precision Payment”, which in turn enables proper bundled payment design, and precision medicine. Read Full Release
Odyssey Logistics & Technology
Odyssey Logistics & Technology Receives Equity Investment from The Jordan Company
08.30.17
Odyssey Logistics & Technology Corporation (Odyssey), a leading global logistics provider, announced today that an affiliate of The Jordan Company has signed a definitive agreement to become the new majority shareholder in Odyssey. Read Full Release
Boston Millennia Parters
Dana Callow to Attend Harvard Medical School’s Precision Medicine 2017: Breakaway Business Models
06.21.17
In this year’s conference on Wednesday, June 21 (agenda below), we address the question of how to implement and disseminate these business models head on. Fortunately there are already several enterprises, some of them led by patients themselves, which provide us early answers to these questions. These are featured in our first panel entitled Early Disruptors in Precision Medicine. Read Full Release
PAREXEL International
Attend the lunch and learn with PRXL on Key Aspects of the FDA’s Drug Development and Review Programs
05.12.17
MassBio Lunch and Learn: Navigating Accelerated Approvals in Today’s Oncology Drug Development Landscape: Ensuring a Properly Tailored Approached Based on FDA Expectations and Current Trends in Drug Development Read Full Release
Boston Millennia Parters
Dana Callow to Speak on The State of The VC Market Panel
11.17.16
ACG Boston's regular networking breakfast returns to Serafina in Boston's financial district. Open to all, the Networking Breakfast is ACG Boston's signature event, where M&A professionals come to network and hear industry experts share their outlook, opinions, successes and failures. Join New England's M&A community on November 17 to hear a panel discussion on the current state of the VC market -- how the industry has evolved and where it's headed in the future. Read Full Release
Boston Millennia Parters
BMP to attend 2016 SBIR New England Regional Summit
10.06.16
The 2016 New England Regional Innovation Summit is a two-day engagement opportunity being held at MIT, for technology innovators and entrepreneurs. This effort, spearheaded by the SBA Office of Investment and Innovation (OII), is a coordinated effort amongst participating SBIR/STTR agencies to continually engage, identify, and encourage participation in the SBIR/STTR programs. The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, affectionately referred as America’s Seed Fund, play an instrumental role in providing early stage, non-dilutive, research and development capital which spurs small advanced technology firms’ innovations. Annually more than $2.5 billion non-diluted in early stage research and development funding is provided through these programs. Read Full Release
Boston Millennia Parters
Dana Callow to be Panelist at Funding Models in Biotech MBBP Life Sciences Series – Panel 3
09.22.16
Today’s financing environment for emerging biotech companies presents a number of challenges. Venture capital funds are ever more cautious about taking risk, and some players have departed the field at the early stage. Government grants have also closed their spigots in recent years, as the volume of government funding has plummeted dramatically. However, new players have entered the fray in the last few years, including family offices, super angels, strategic partners and foreign investors, replacing the investment dollars previously offered by institutional investors. So where does an emerging biotech company forage for precious dollars? Come join us on September 22nd at the CIC in Cambridge to hear a panel of experts discuss these trends. At the event, you will discover, among other ideas: Where and how to find the new players; What areas of interest are these players financing; How to optimize your chances of success; What are deal structures looking like? Read Full Release
Boston Millennia Parters
2016 Wells Fargo Healthcare Conference
09.07.16
Please join us on September 7-8 for the 11th Annual Wells Fargo Securities Healthcare Conference in Boston. Read Full Release
Boston Millennia Parters
Dana Callow to be on Lifescience Panel at the Richi Immersion Summer 2016 Program
07.21.16
Richi Social Entrepreneurs is a Richi Foundation initiative whose mission is to foster and catalyze the development of international Social Entrepreneurship ecosystems, taking Boston's unique case as our role model. Richi Social Entrepreneurs Immersion Summer 2016 is a one-month eye-opening experience in Boston. Social Entrepreneurs have the opportunity to explore Boston's advanced Social Innovation ecosystems, while working on their social value proposition and problem-solution fit. Social Entrepreneurs wear different hats, from startup founders in BioTech, HealthCare or Education, to professionals working in IT, CleanTech or Finance. It's not the industry that determines a project's potential social impact, it's the drive and motivation of the entrepreneur behind the idea. Read Full Release
Boston Millennia Parters
Dana Callow to Speak at Cancer Moonshot Summit
06.29.16
Boston Millennia Partners’ Dana Callow to Speak at Cancer Moonshot Summit. Simultaneous events will take place at the same time throughout the country to improve awareness of the program and gain support for funding research. Representatives from major pharmaceutical companies and service providers including Takeda, Syapse, and Foundation Medicine well as researchers from the area will speak about the Moonshot and their roles in finding a cure. The White House is sponsoring The National Cancer Moonshot summit. Vice President Joe Biden will speak on behalf of the program and subsequently there will be panel discussions by leading cancer specialists and patient advocates. As a Board Member of the National Leukemia Society Dana will address how non-profit organizations can positively impact the effort to find cures and improve patient care. Location: MGH Cancer Center, Lawrence House, 1st Floor Conference Room, 10 North Grove St., Boston MA Please contact liz@bmpvc.com for the speaker guide Read Full Release
Boston Millennia Parters
Dana Callow to be Panelist at Funding Models in Biotech MBBP Life Sciences Series – Panel 3
09.22.16
Today’s financing environment for emerging biotech companies presents a number of challenges. Venture capital funds are ever more cautious about taking risk, and some players have departed the field at the early stage. Government grants have also closed their spigots in recent years, as the volume of government funding has plummeted dramatically. However, new players have entered the fray in the last few years, including family offices, super angels, strategic partners and foreign investors, replacing the investment dollars previously offered by institutional investors. So where does an emerging biotech company forage for precious dollars? Come join us on September 22nd at the CIC in Cambridge to hear a panel of experts discuss these trends. At the event, you will discover, among other ideas: Where and how to find the new players; What areas of interest are these players financing; How to optimize your chances of success; What are deal structures looking like? Read Full Release
Boston Millennia Parters
David Carney to Attend CED Tech Venture Conference
09.13.16
From early startups to growth-stage companies to highly successful businesses, the CED Tech Venture Conference reflects North Carolina’s vibrant entrepreneurial community and showcases many of the most-promising emerging companies in the region. Attendees will have the opportunity to connect with a diverse group of over 100 investors, from venture capital to corporate to angels, including funds such as Sequoia Capital, Greycroft, Grotech Ventures, and Comcast Ventures. Engage with industry leaders, radical thinkers and trail-blazing entrepreneurs, and learn about the disruptive innovations that are transforming the ways in which we live, work and play. Read Full Release
Boston Millennia Parters
Dana Callow to be on Lifescience Panel at the Richi Immersion Summer 2016 Program
07.21.16
Richi Social Entrepreneurs is a Richi Foundation initiative whose mission is to foster and catalyze the development of international Social Entrepreneurship ecosystems, taking Boston's unique case as our role model. Richi Social Entrepreneurs Immersion Summer 2016 is a one-month eye-opening experience in Boston. Social Entrepreneurs have the opportunity to explore Boston's advanced Social Innovation ecosystems, while working on their social value proposition and problem-solution fit. Social Entrepreneurs wear different hats, from startup founders in BioTech, HealthCare or Education, to professionals working in IT, CleanTech or Finance. It's not the industry that determines a project's potential social impact, it's the drive and motivation of the entrepreneur behind the idea. Read Full Release
Boston Millennia Parters
Dana Callow to Speak at Cancer Moonshot Summit
06.29.16
Boston Millennia Partners’ Dana Callow to Speak at Cancer Moonshot Summit. Simultaneous events will take place at the same time throughout the country to improve awareness of the program and gain support for funding research. Representatives from major pharmaceutical companies and service providers including Takeda, Syapse, and Foundation Medicine well as researchers from the area will speak about the Moonshot and their roles in finding a cure. The White House is sponsoring The National Cancer Moonshot summit. Vice President Joe Biden will speak on behalf of the program and subsequently there will be panel discussions by leading cancer specialists and patient advocates. As a Board Member of the National Leukemia Society Dana will address how non-profit organizations can positively impact the effort to find cures and improve patient care. Location: MGH Cancer Center, Lawrence House, 1st Floor Conference Room, 10 North Grove St., Boston MA Please contact liz@bmpvc.com for the speaker guide Read Full Release
PAREXEL International
PAREXEL Experts to Discuss Key Drug Development Insights at DIA 2016
06.20.16
BOSTON, June 20, 2016— PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that several of its experts will discuss key issues facing the industry at the 52nd Annual Drug Information Association (DIA) meeting, held from June 26-30, 2016 in Philadelphia. Read Full Release
PAREXEL International
PAREXEL Announces Master Services Agreement with Pfizer
06.10.16
BOSTON, June 10, 2016 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has signed a services agreement with Pfizer Inc. Under the terms of this agreement, PAREXEL will continue to provide global clinical research and development services to Pfizer in support of clinical development programs across its portfolio. Terms of the agreement were not disclosed. Read Full Release
PAREXEL International
PRXL to Present at Cambridge Healthtech Institute’s Twelfth Annual Biomarkers & Diagnostics World Congresss 2016
05.18.16
Presentation: Wednesday, May 18 - 9:20 am Extending Precision Medicine Beyond Oncology Arlene Hughes, Senior Director, Genomic Medicine, Clinical Research Services Visit PAREXEL at Booth 4 in the Exhibit Hall. Read Full Release
Odyssey Logistics & Technology
Odyssey Logistics & Technology (Odyssey) at World of Concrete Trade Show
02.02.15
Odyssey will have representatives from its business service, Web Integrated Network (WIN) at booth C4123. Visitors are welcome to stop by the booth to learn more about this web-based logistics management capability, and meet WIN team member, Phil Villapiano, former American football star and champion Read Full Release